Novara Therapeutics, an antiviral drug discovery company, has secured $23m in Series A financing to support the development of capsid-targeting antivirals to treat chronic hepatitis B (HBV) and HIV infections. The company's antiviral ...
Tags: antiviral drug discovery company, chronic hepatitis, HIV infections
TTY Biopharm Co.,Ltd.,a major pharmaceutical maker in Taiwan,recently inaugurated a drug factory in Suzhou,Jiangsu Province of China,operated by TTY`s Chinese subsidiary TOT Biopharm Co.,Ltd. At a cost of about US$100 million,the factory ...
Tags: TTY Biopharm, drug factory, anti-cancer drug injections, Suzhou
Ranbaxy Laboratories has unveiled Synriam in India, to treat uncomplicated Plasmodium falciparum malaria, in adults. The Drug Controller General of India approved the new drug, indicated for relief from malaria-related symptoms, for ...
Tags: Malaria Drug, Synriam, malaria
Prosetta Antiviral has entered into a multi-year collaboration with Bristol-Myers Squibb Company to further discover and develop select drug candidates representing new, novel classes of antiviral drugs. The collaboration will focus on ...
Tags: lect drug candidates, antiviral drugs, viral infections
Fundacion MEDINA has entered into a contract research collaboration with Cubist Pharmaceuticals to discover novel antibiotics from Cubist's and MEDINA's proprietary and natural product libraries. The alliance will be focused on going ...
Tags: Research Collaboration, Cubist's drug, anti-bacterial drugs
Galapagos, a mid-size biotechnology company, has delivered the first pre-clinical candidate compound in its osteoarthritis alliance with Servier. Servier and Galapagos entered into an alliance in July 2010 to develop new oral medicines ...
Tags: Galapagos Identifies Drug, Galapagos, Servier, osteoarthritis
Pulmatrix has demonstrated iSPERSE capabilities for inhaled dry powder delivery of antibiotics, antibodies and other macromolecules. These preclinical data demonstrated the ability of iSPERSE formulations to deliver stable and ...
The package, which will launch at more than 3,600 Walmart pharmacies this summer, features a tear-resistant, recyclable outer carton, an easy-slide blister and an integrated calendar for patients to easily track their medications. ...
Aegis Therapeutics has received a US patent covering Parathyroid Hormone (PTH) and PTH analogue compositions suitable for metered nasal spray, oral, and injectable delivery. The stabilized PTH formulations incorporate Aegis' ...
Tags: Aegis Therapeutics, PTH formulations, Intravail and ProTek excipients
The University of Washington (UW), University of Texas Medical Branch (UTMB) at Galveston, US, and Kineta have been granted a $8.1m biodefense award by the National Institute of Allergy and Infectious Diseases (NIAID). The funding aims to ...
Tags: the National Institute of Allergy and Infectious Diseases
AbD Serotec, MorphoSys' division for research and diagnostic antibodies, is set to introduce a series of the human combinatorial antibody library (HuCAL) anti-drug antibodies supporting the development of novel antibody therapeutics. The ...
Tags: AbD Serotec, HuCAL Anti-Drug Antibodies, antibody therapeutics, MorphoSys
Cytochroma has announced termination of a license agreement with Mitsubishi Tanabe Pharma (MTPC) thereby regaining rights to all indications of lunacalcipol indications in the US and in Asian territories. The companies mutually decided to ...
Tags: Cytochroma, Mitsubishi Tanabe Pharma, lunacalcipol indications
AET BioTech and BioXpress Therapeutics have signed a research deal for the development of a biosimilar version of the TNF inhibitor MAb Adalimumab. Under the agreement, both the companies will be responsible for the development, ...
Tags: AET BioTech, BioXpress Therapeutics, TNF Inhibitor, research deal
Injectable drugs device and component solutions provider West has commercially introduced its B.safe syringe safety system. The system is expected to protect against needlestick injury when using a prefilled syringe, according to West. ...
Tags: syringe safety system, needlestick injury, prefilled syringe
American Regent has issued a retail/hospital level recall of Epinephrine Injection, USP, because of discoloration and small visible particles found in some ampules of lot #1395. The adverse events after intravenous administration of ...
Tags: Epinephrine Injection, USP, Luitpold Pharmaceuticals, American Regent